Postdoctoral Fellow
BIOGRAPHY
JUN 21, 2022 10:00 AM PDT
Using cutting-edge stem cell technology to model human cardiac diseases
Speaker
Event Date & Time
Date: June 21, 2022
Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST)
Abstract
Human-induced pluripotent stem cell (iPSC) technology allows for “clinical trials in-a-dish” because patient characteristics can be maintained in cell culture which provides limitless material for research initiatives. Previously, cardiac diseases were difficult to study due to inherent differences in small animal models as well as barriers to patient biopsies. Today, the advent of stem cell technology provides an exciting research strategy with direct human relevance to cardiac disease.
In this talk, we will highlight:
- How iPSCs are generated from patient blood samples and maintained in culture
- How iPSCs can be differentiated into the cardiac cell types
- How patient-derived iPSC cells can be used to study diseases and find therapies
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
Loading Comments...